Everyone- I'm currently traveling in Barcelona. I visited

New Post Public Reply Private Reply Replies (1) Message Board
fourthjohn
Everyone- I'm currently traveling in Barcelona. I visited Hospital Cima Sanitas. Without prior notice, I found the Endoscopy unit of the Hospital. With my limited Spanish, I was able to find Chief of Endoscopy Dr. Ramon Abad and his colleague Dr. Pedro Ruiz Garcia. Dr. Ruiz allowed me to interview him and he spoke highly of the WavStat4. They were awaiting the results of the biopsy to be able to write their opinion of the results. Dr. Garcia said the WavStat4 was very easy to use and was easy to remove the polyps. He said they were anxious to use it on more patients. He believed the WavSTAT was a definite improvement over current technology. Once the results come in, they will make their recommendations to administration and administration would do the purchasing. I will post Dr. Garcia's interview later.

In the second interview (which I have posted) with both Abad and Garcia, once again, they confirmed ease of use and accuracy. He said the procedures were all done easily and accurately. He said the only improvement could be in creating forceps that were for multiple uses, not single disposable items. Also, he did say that he may have found another application for the WavStat for another kind of tumor, which he thought was promising.

I have to say it was very nice meeting actual department heads of a hospital that have actually used the WavSTAT4 and we're truly excited over the possibilities. They knew I was a shareholder simply enquiring about their experience with the machine. These two doctors were super busy and still agreed to be video taped.

Guys, we have a winner. Hold the line. We have something white hot on our hands.

https://youtu.be/Esn4MaAxXC4

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Solis Agrosciences Gains Series A Funding to Drive Growth Forward

Updated Category News Views 272

Solis Agrosciences Gains Series A Funding to Drive Growth Forward Solis Agrosciences, a prominent name in the Agtech sector, has announced a significant milestone in its journey of innovation and growth. The company has successfully secured Series A funding from Cultivation Capital, an investment that promises to amplify its business operations and expand its array of...

Continue Reading
Blink Charging: Milestone Achievements and Future Outlook

Updated Category News Views 283

Update on Blink Charging and Its Stock Performance Blink Charging Co. (NASDAQ: BLNK) shares saw an upward trend recently, as the company proudly announced it surpassed 100,000 electric vehicle (EV) chargers sold, deployed, or contracted globally. This significant accomplishment highlights Blink's growth in the EV infrastructure sector. The company's success can be...

Continue Reading
Vanguard Unveils Innovative Active Equity ETF Range

Updated Category News Views 228

Vanguard Launches New Active Equity ETFs Vanguard has recently introduced three active equity ETFs aimed at enhancing investor portfolio options. The newly launched funds are the Vanguard Wellington U.S. Value Active ETF (VUSV), Vanguard Wellington U.S. Growth Active ETF (VUSG), and Vanguard Wellington Dividend Growth Active ETF (VDIG), each managed by the esteemed...

Continue Reading
New COVID-19 Vaccine by Pfizer and BioNTech Shows Promise

Updated Category News Views 244

Revamped Approach to COVID-19 Vaccination In a noteworthy advancement in the fight against the COVID-19 pandemic, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) are set to introduce an LP.8.1-adapted monovalent COVID-19 vaccine following a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)....

Continue Reading
Gold's Steady Climb Amid Geopolitical Tensions and Economic Shifts

Updated Category News Views 210

Gold Rises for Third Consecutive Session Gold (XAU/USD) has shown a steady increase of over 0.32%, reflecting a notable rise in safe-haven demand driven by global trade tensions. Investors remain concerned about the stability of global supply chains, making gold a popular choice during times of uncertainty. The yellow metal typically shines as a safe-haven asset when...

Continue Reading